Fuhrmann syndrome

Fuhrmann syndrome is an extremely rare genetic disorder characterized by congenital skeletal abnormalities, primarily affecting the lower limbs. The hallmark features include bilateral aplasia or hypoplasia of the fibula (absence or underdevelopment of the smaller bone of the lower leg), bowing of the femora (thighbones), and poly-, oligo-, or syndactyly of the fingers and toes (extra digits, missing digits, or fused digits). Additional limb anomalies may include absent or hypoplastic nails and shortened or malformed long bones. The condition is present at birth and can significantly affect mobility and limb function. Fuhrmann syndrome primarily affects the musculoskeletal system, with the lower extremities being most severely involved. The upper limbs may also show anomalies, though typically to a lesser degree. Intelligence and cognitive development are generally reported as normal. The condition was first described by Fuhrmann and colleagues in a consanguineous family, supporting an autosomal recessive inheritance pattern. Due to the extreme rarity of this condition, the molecular genetic basis has not been fully elucidated, though mutations in the WNT7A gene have been implicated in some cases, linking it to other limb malformation syndromes in the same gene family. There is no cure for Fuhrmann syndrome. Treatment is supportive and symptomatic, focusing on orthopedic interventions to improve limb function and mobility. Surgical correction of limb deformities, prosthetic devices, and physical therapy may be employed depending on the severity of the skeletal anomalies. A multidisciplinary approach involving orthopedic surgeons, geneticists, and rehabilitation specialists is recommended for optimal management.

Common questions about Fuhrmann syndrome